New results From a Clinical Trial Using MDMA to Treat PTSD Showed the Promise of a Stigmatized Drug to Treat Mental Illness at a Time When Covid-19 Has Raised Global Awareness of the Toll of Mental Health Conditions
Decriminalization of drugs like “magic” mushrooms in places including Denver and Oregon may lead to broader public acceptance, but the emerging alternative drug industry is focused on patients most in need and where current psychiatric medications have failed. Companies like
Compass Pathways (NASDAQ:CMPS), which uses psilocybin for depression, and ATAI Life Sciences, backed by Peter Thiel, are researching a variety of ways to treat mental health with alternative and psychedelic therapies.